Company Filing History:
Years Active: 2005-2007
Title: Innovator Jong-ho Kim: Pioneering Selective Inhibitors in Gyeonggi-do, KR
Introduction: Jong-ho Kim is a notable inventor based in Gyeonggi-do, South Korea, recognized for his contributions to the field of pharmaceutical compounds. With a total of three patents to his name, Kim's innovative work focuses primarily on highly selective cyclooxygenase-2 inhibitors, which play a vital role in the treatment of various inflammatory conditions.
Latest Patents: Among his recent inventions are diaryl 1,2,4-triazole derivatives recognized for their efficacy as selective cyclooxygenase-2 inhibitors. The first patent details a novel diaryl 1,2,4-triazole derivative described by a specific formula designed to selectively inhibit cyclooxygenase-2 activity. The second patent emphasizes a similar compound, reiterating its significance as a highly selective inhibitor, also detailed by its unique formula.
Career Highlights: Jong-ho Kim is currently employed at CJ Corporation, where he is engaged in cutting-edge research and development. His work has not only resulted in valuable patents but also positions him as a key player in his field, driving forward innovations that may influence the pharmaceutical industry.
Collaborations: Throughout his career, Kim has collaborated with distinguished coworkers, including Il-Hwan Cho and Jee-Woong Lim. Together, they contribute their collective expertise to enhance the quality and impact of their innovations.
Conclusion: Jong-ho Kim stands as a prominent figure in the realm of pharmaceutical inventions, with significant contributions to selective inhibition research. His ongoing work at CJ Corporation and recent patents reflect his commitment to innovating effective treatments, marking him as an inventor to watch in the evolving landscape of medical science.